Skp2 p45 siRNA (h) from Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

(1) L-Arginine Enhances Oral Keratinocyte Proliferation under High-Glucose Conditions via Upregulation of CYP1A1, SKP2, and SRSF5MoleculesOctober 10, 2023Junhe Shi, Trevor R. Leonardo, Chen Han, Hiba I. Bangash, Dandan Chen, Harsh M. Trivedi, Lin Chenwith 20 nM siRNAs for CYP1A1, SKP2, and SRSF5 (Santa Cruz Biotechnology, Catalog number: sc-41483, sc-36499, and sc-38342, respectively) or with a scrambled siRNA control (Santa Cruz Biotechnology, Catalog number:

(3) CDK2-instigates C/EBPα degradation through SKP2 in Acute myeloid leukemiaMedical oncology (Northwood, London, England)May 17, 2021Thacker G, Mishra M, Sharma A, Singh AK, Sanyal S, Trivedi AK.

(4) E3 ligase SCF(SKP2) ubiquitinates and degrades tumor suppressor C/EBPα in acute myeloid leukemiaLife sciencesSeptember 15, 2020Thacker G, Mishra M, Sharma A, Singh AK, Sanyal S, Trivedi AK.

(7) Skp2 inhibits osteogenesis by promoting ubiquitin-proteasome degradation of Runx2Biochimica et biophysica actaApril 1, 2016Thacker G, Kumar Y, Khan MP, Shukla N, Kapoor I, Kanaujiya JK, Lochab S, Ahmed S, Sanyal S, Chattopadhyay N, et al.

(8) Wnt7a is a novel inducer of β-catenin-independent tumor-suppressive cellular senescence in lung cancerOncogeneOctober 16, 2015Rama Kamesh Bikkavilli et al.Wnt7a siRNAs (SI0006620) were obtained from Qiagen (Venlo, Limburg, the Netherlands). SKP2 siRNAs (sc-36499) were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Western blotting analysis Lung

(9) Inhibition of S-phase kinase-associated protein 2-mediated p27 degradation suppresses tumorigenesis and the progression of hepatocellular carcinomaMolecular medicine reportsMay 1, 2015Qi M, Liu D, Zhang S, Hu P, Sang T.subsequent to transfection for 48 h. The Skp2 p45 siRNA was purchased from Santa Cruz Biotechnology, Inc. (sc‑36499; Dallas, TX, USA) and scramble siRNA was synthesized by Shanghai Jima Company (Shanghai, China). Rabbit

(10) The role of homeostatic regulation between tumor suppressor DAB2IP and oncogenic Skp2 in prostate cancer growthOncotargetAugust 15, 2014Tsai YS, Lai CL, Lai CH, Chang KH, Wu K, Tseng SF, Fazli L, Gleave M, Xiao G, Gandee L, et al.

(14) Androgen depletion induces senescence in prostate cancer cells through down-regulation of Skp2Neoplasia (New York, N.Y.)June 1, 2011Pernicová Z, Slabáková E, Kharaishvili G, Bouchal J, Král M, Kunická Z, Machala M, Kozubík A, Souček K.

(16) SKP2 and CKS1 promote degradation of cell cycle regulators and are associated with hepatocellular carcinoma prognosisGastroenterologyNovember 1, 2009Calvisi DF, Ladu S, Pinna F, Frau M, Tomasi ML, Sini M, Simile MM, Bonelli P, Muroni MR, Seddaiu MA, et al.

(20) p21 and p27 induction by silibinin is essential for its cell cycle arrest effect in prostate carcinoma cellsMolecular cancer therapeuticsOctober 1, 2007Roy S, Kaur M, Agarwal C, Tecklenburg M, Sclafani RA, Agarwal R.

(1)

7/19/2022SKP2 siRNA Knocking Down SKP2 in Keratinocytes Lin ChenThe aim was to knock down SKP2 in human oral keratinocytes and examine if knocking down SKP2 wound impairs cell proliferation. By following the protocol, SKP2 siRNA did its job.

Skp2 p45 siRNA (h)